Myosin Light Chain 2 Antibody | Cell Signaling Technology
Myosin Light Chain 2 Antibody detects endogenous levels of total Myosin Light Chain 2 (smooth muscle). This antibody does not cross-react with the cardiac isoform of Myosin Light Chain 2, …
MYL2 - Wikipedia
Myosin regulatory light chain 2, ventricular/cardiac muscle isoform (MLC-2) also known as the regulatory light chain of myosin (RLC) is a protein that in humans is encoded by the MYL2 …
Myosin light chain - Wikipedia
Myosin light chains (MLCs) can be broadly classified into two groups: Regulatory MLC (MLC2 or RLC). Essential and regulatory MLCs have molecular masses of 22 and 19 kDa, respectively. …
Functions of Myosin Light Chain-2 (MYL2) In Cardiac Muscle and …
Myosin light chain-2 (MYL2, also called MLC-2) is an ∼19 kDa sarcomeric protein that belongs to the EF-hand calcium binding protein superfamily and exists as three major isoforms encoded …
MYL2 Gene - GeneCards | MLRV Protein | MLRV Antibody
Dec 25, 2024 · MYL2 (Myosin Light Chain 2) is a Protein Coding gene. Diseases associated with MYL2 include Cardiomyopathy, Familial Hypertrophic, 10 and Myopathy, Myofibrillar, 12, …
MLC2: Physiological Functions and Potential Roles in Tumorigenesis
3 days ago · The myosin regulatory light chain 2 (MLC2) is a crucial regulator of myosin activity. Its phosphorylation, mediated by various kinases, plays a vital role in maintaining normal …
肌球蛋白轻链 2（MYL2）基因 | MCE - MCE-生物活性分子大师
该基因编码哺乳动物横纹肌中的一种主要肌节蛋白。 编码的蛋白质在胚胎心肌结构和功能中发挥作用，而编码蛋白质的磷酸化参与成人的心肌肌球蛋白循环动力学、扭转和功能。 该基因的突 …
综述：肌球蛋白调节轻链 2（MLC2）的磷酸化调控机制及其在生 …
3 days ago · mlc 2 的磷酸化过程由多种激酶介导。 这些激酶如同一个个 “信号使者”，在不同的细胞环境和生理条件下被激活，然后将磷酸基团添加到 mlc 2 特定的氨基酸残基上，改变其结构 …
MLC2: Physiological Functions and Potential Roles in Tumorigenesis
The myosin regulatory light chain 2 (MLC2) is a crucial regulator of myosin activity. Its phosphorylation, mediated by various kinases, plays a vital role in maintaining normal …
肌球蛋白调节性轻链磷酸化在心脏疾病中的研究进展_百度文库
mlc2主要存在四种亚型：非肌型、平滑肌型、骨骼肌型和心肌型。 心肌型又有心房型(MLC2a)和心室型(MLC2v)，这两型的基因具有高度同源性，它们的初级氨基酸序列有56%的一致性和86% …